Trading Markets -- Leading Biogen Idec Inc. investor Carl Icahn said documents the company was forced to file to the Securities and Exchange Commission as a result of a lawsuit connected with the failed sale of the company last year contain many “inconsistencies” and “a number” of untruths.
